Institute of Social and Preventive Medicine (ISPM), University of Berne, Berne, Switzerland.
Eur Respir J. 2010 Dec;36(6):1248-58. doi: 10.1183/09031936.00001010. Epub 2010 Jun 7.
Primary ciliary dyskinesia (PCD) is a hereditary disorder of mucociliary clearance causing chronic upper and lower airways disease. We determined the number of patients with diagnosed PCD across Europe, described age at diagnosis and determined risk factors for late diagnosis. Centres treating children with PCD in Europe answered questionnaires and provided anonymous patient lists. In total, 223 centres from 26 countries reported 1,009 patients aged < 20 yrs. Reported cases per million children (for 5-14 yr olds) were highest in Cyprus (111), Switzerland (47) and Denmark (46). Overall, 57% were males and 48% had situs inversus. Median age at diagnosis was 5.3 yrs, lower in children with situs inversus (3.5 versus 5.8 yrs; p < 0.001) and in children treated in large centres (4.1 versus 4.8 yrs; p = 0.002). Adjusted age at diagnosis was 5.0 yrs in Western Europe, 4.8 yrs in the British Isles, 5.5 yrs in Northern Europe, 6.8 yrs in Eastern Europe and 6.5 yrs in Southern Europe (p < 0.001). This strongly correlated with general government expenditures on health (p < 0.001). This European survey suggests that PCD in children is under-diagnosed and diagnosed late, particularly in countries with low health expenditures. Prospective studies should assess the impact this delay might have on patient prognosis and on health economic costs across Europe.
原发性纤毛运动障碍(PCD)是一种遗传性黏液纤毛清除功能障碍疾病,可引起慢性上、下呼吸道疾病。我们确定了欧洲确诊 PCD 患者的数量,描述了诊断时的年龄,并确定了导致诊断延迟的危险因素。欧洲治疗 PCD 儿童的中心回答了调查问卷并提供了匿名患者名单。共有来自 26 个国家的 223 个中心报告了 1009 名年龄<20 岁的患者。塞浦路斯(111 例)、瑞士(47 例)和丹麦(46 例)报告的每百万儿童病例数(5-14 岁)最高。总体而言,57%为男性,48%存在内脏转位。诊断时的中位年龄为 5.3 岁,内脏转位患者的年龄较小(3.5 岁比 5.8 岁;p<0.001),且在大型中心治疗的儿童年龄也较小(4.1 岁比 4.8 岁;p=0.002)。西欧调整后的诊断年龄为 5.0 岁,不列颠群岛为 4.8 岁,北欧为 5.5 岁,东欧为 6.8 岁,南欧为 6.5 岁(p<0.001)。这与政府卫生总支出呈强相关(p<0.001)。这项欧洲调查表明,儿童 PCD 诊断不足且诊断较晚,尤其是在卫生支出较低的国家。前瞻性研究应评估这种延迟可能对患者预后以及整个欧洲卫生经济成本产生的影响。